Journal of Clinical Oncology: Phase 1 study of pritumumab in brain cancer.
Jose Arganda Carrillo, Santosh Kesari, Jaya Mini Gill, Charles Redfern, Sean Carrick, Ivan Babic Background: Pritumumab, a fully human IgG1 (kappa) monoclonal antibody (mAb), was originally [...]